[Federal Register Volume 75, Number 75 (Tuesday, April 20, 2010)]
[Notices]
[Page 20608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2010-9056]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0001]
Risk Communication Advisory Committee; Notice of Meeting
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
This notice announces a forthcoming meeting of a public advisory
committee of the Food and Drug Administration (FDA). The meeting will
be open to the public.
Name of Committee: Risk Communication Advisory Committee.
General Function of the Committee: To provide advice and
recommendations to the agency on FDA's regulatory issues.
Date and Time: The meeting will be held on May 6, 2010, from 8 a.m.
to 5 p.m. and May 7, 2010, from 8 a.m. to 2 p.m.
Location: FDA White Oak Campus, 10903 New Hampshire Ave., Bldg. 31,
Conference Center (rm. 1503), Silver Spring, MD 20993. Please note that
all visitors must park in the visitors' parking lot near Building 22
(for a campus map, see http://www.fda.gov/AboutFDA/WorkingatFDA/BuildingsandFacilities/WhiteOakCampusInformation/default.htm). The
Campus is also served by several bus lines connecting to metro rail
(see http://www.wmata.com/).
Contact Person: Lee L. Zwanziger, Office of the Commissioner,
Office of Policy, Planning and Preparedness, Office of Planning, Food
and Drug Administration, 5600 Fishers Lane, rm. 14-90, Rockville, MD
20857, 301-827-2895, FAX: 301-827-4050, e-mail: [email protected] , or
FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572
in the Washington, DC area), code 8732112560. Please call the
Information Line for up-to-date information on this meeting. A notice
in the Federal Register about last minute modifications that impact a
previously announced advisory committee meeting cannot always be
published quickly enough to provide timely notice. Therefore, you
should always check the agency's Web site and call the appropriate
advisory committee hot line/phone line to learn about possible
modifications before coming to the meeting.
Agenda: On May 6 and 7, 2010, the Committee will review the state
of current research in a range of fields relevant to improving risk
communication at FDA, and discuss applications or gaps for strategic
planning of risk communication at FDA. For more specific agenda
information, please visit the following Web site and scroll down to the
appropriate advisory committee link (http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm), or call FDA Advisory
Committee Information Line as listed above in the Contact Person
section of the notice. FDA intends to make agenda information available
at both these locations no later than 15 days before the meeting.
FDA intends to make background material available to the public no
later than 2 business days before the meeting. If FDA is unable to post
the background material on its Web site prior to the meeting, the
background material will be made publicly available at the location of
the advisory committee meeting, and the background material will be
posted on FDA's Web site after the meeting. Background material is
available at http://www.fda.gov/AdvisoryCommittees/Calendar/default.htm. Scroll down to the appropriate advisory committee link.
Procedure: Visitors to the White Oak Campus must have a valid
driver's license or other picture ID, and must enter through Building
1. In order to help speed entrance through security, we request that
attendees send an email giving their full names to [email protected]
with the word ``registration'' in the subject line, or telephone Lee
Zwanziger (see Contact Person), by April 27, 2010.
Interested persons may present data, information, or views, orally
or in writing, on issues pending before the committee. Written
submissions may be made to the contact person on or before May 3, 2010.
Oral presentations from the public will be scheduled between
approximately 3:15 p.m. and 4:15 p.m. on May 6, 2010, and between 1
p.m. and 1:30 p.m. on May 7, 2010. Those desiring to make formal oral
presentations should notify Lee Zwanziger and submit a brief statement
of the general nature of the evidence or arguments they wish to
present, the names and addresses of proposed participants, and an
indication of the approximate time requested to make their presentation
on or before April 27, 2010. Time allotted for each presentation may be
limited. If the number of registrants requesting to speak is greater
than can be reasonably accommodated during the scheduled open public
hearing session, FDA may conduct a lottery to determine the speakers
for the scheduled open public hearing session. The contact person will
notify interested persons regarding their request to speak by April 28,
2010.
Persons attending FDA's advisory committee meetings are advised
that the agency is not responsible for providing access to electrical
outlets.
FDA welcomes the attendance of the public at its advisory committee
meetings and will make every effort to accommodate persons with
physical disabilities or special needs. If you require special
accommodations due to a disability, please contact Lee Zwanziger at
least 7 days in advance of the meeting.
FDA is committed to the orderly conduct of its advisory committee
meetings. Please visit our Web site at http://www.fda.gov/AdvisoryCommittees/AboutAdvisoryCommittees/ucm111462.htm for procedures
on public conduct during advisory committee meetings.
Notice of this meeting is given under the Federal Advisory
Committee Act (5 U.S.C. app. 2).
Dated: April 14, 2010.
Jill H. Warner,
Acting Associate Commissioner for Special Medical Programs.
[FR Doc. 2010-9056 Filed 4-19-10; 8:45 am]
BILLING CODE 4160-01-S